Latest Insider Transactions at Anaptysbio, Inc (ANAB)
This section provides a real-time view of insider transactions for Anaptysbio, Inc (ANAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ANAPTYSBIO, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ANAPTYSBIO, INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 15
2026
|
Magda Marquet |
SELL
Open market or private sale
|
Direct |
11,000
-29.54%
|
$528,000
$48.48 P/Share
|
|
Jan 15
2026
|
Magda Marquet |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+34.45%
|
$286,000
$26.11 P/Share
|
|
Jan 08
2026
|
Paul F. Lizzul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,650
-7.98%
|
$160,600
$44.71 P/Share
|
|
Jan 08
2026
|
Daniel Faga President, CEO |
SELL
Open market or private sale
|
Direct |
14,281
-2.89%
|
$628,364
$44.71 P/Share
|
|
Jan 08
2026
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,210
-14.69%
|
$97,240
$44.71 P/Share
|
|
Jan 08
2026
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,515
-10.32%
|
$110,660
$44.71 P/Share
|
|
Jan 07
2026
|
Paul F. Lizzul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,525
+15.71%
|
-
|
|
Jan 07
2026
|
Daniel Faga President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,838
+5.16%
|
-
|
|
Jan 07
2026
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,888
+28.13%
|
-
|
|
Jan 07
2026
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,700
+21.57%
|
-
|
|
Jan 07
2026
|
Daniel Faga President, CEO |
SELL
Open market or private sale
|
Direct |
9,202
-1.93%
|
$414,090
$45.11 P/Share
|
|
Jan 07
2026
|
Paul F. Lizzul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,235
-5.67%
|
$100,575
$45.11 P/Share
|
|
Jan 07
2026
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,639
-15.85%
|
$433,755
$45.96 P/Share
|
|
Jan 07
2026
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,908
-9.75%
|
$85,860
$45.11 P/Share
|
|
Jan 06
2026
|
Daniel Faga President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,850
+3.61%
|
-
|
|
Jan 06
2026
|
Paul F. Lizzul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,145
+13.48%
|
-
|
|
Jan 06
2026
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,545
+22.78%
|
-
|
|
Jan 06
2026
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,245
+21.13%
|
-
|
|
Jan 05
2026
|
Paul F. Lizzul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,219
-11.24%
|
$181,417
$43.26 P/Share
|
|
Jan 05
2026
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,363
-19.01%
|
$144,609
$43.26 P/Share
|
|
Jan 05
2026
|
Daniel Faga President, CEO |
SELL
Open market or private sale
|
Direct |
15,309
-3.23%
|
$658,287
$43.26 P/Share
|
|
Jan 05
2026
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,983
-18.38%
|
$128,269
$43.26 P/Share
|
|
Jan 03
2026
|
Paul F. Lizzul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,555
+21.95%
|
-
|
|
Jan 03
2026
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,292
+31.91%
|
-
|
|
Jan 03
2026
|
Daniel Faga President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
34,677
+6.82%
|
-
|
|
Jan 03
2026
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,287
+30.98%
|
-
|
|
Dec 23
2025
|
J. Anthony Ware |
SELL
Open market or private sale
|
Direct |
3,900
-28.82%
|
$191,100
$49.58 P/Share
|
|
Dec 23
2025
|
John P. Schmid |
SELL
Other acquisition or disposition
|
Indirect |
11,068
-100.0%
|
$564,468
$51.0 P/Share
|
|
Dec 22
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-52.78%
|
$510,000
$51.0 P/Share
|
|
Dec 22
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.55%
|
$140,000
$14.02 P/Share
|
|
Dec 22
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-51.54%
|
$500,000
$50.0 P/Share
|
|
Dec 22
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.01%
|
$200,000
$20.16 P/Share
|
|
Dec 22
2025
|
Paul F. Lizzul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,500
-5.27%
|
$75,000
$50.0 P/Share
|
|
Dec 22
2025
|
Paul F. Lizzul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+5.01%
|
$27,000
$18.5 P/Share
|
|
Dec 18
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
141
-1.55%
|
$6,486
$46.99 P/Share
|
|
Dec 17
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-52.39%
|
$460,000
$46.0 P/Share
|
|
Dec 17
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.38%
|
$140,000
$14.02 P/Share
|
|
Dec 16
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,725
-38.81%
|
$691,900
$44.91 P/Share
|
|
Dec 16
2025
|
Dennis Mulroy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.47%
|
$200,000
$20.16 P/Share
|
|
Dec 16
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
12,500
-35.03%
|
$550,000
$44.96 P/Share
|
|
Dec 16
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+25.99%
|
$212,500
$17.09 P/Share
|
|
Sep 30
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,240
-47.55%
|
$238,960
$29.0 P/Share
|
|
Sep 30
2025
|
Eric J Loumeau CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+22.39%
|
$70,000
$14.02 P/Share
|
|
Sep 15
2025
|
John A Orwin |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+10.87%
|
-
|
|
Aug 08
2025
|
Hollings Renton |
SELL
Open market or private sale
|
Direct |
10,231
-39.69%
|
$194,389
$19.57 P/Share
|
|
Aug 08
2025
|
Hollings Renton |
BUY
Exercise of conversion of derivative security
|
Direct |
10,231
+40.24%
|
$61,386
$6.93 P/Share
|
|
Jul 02
2025
|
Hollings Renton |
SELL
Open market or private sale
|
Direct |
20,925
-50.68%
|
$481,275
$23.46 P/Share
|
|
Jul 02
2025
|
Hollings Renton |
BUY
Exercise of conversion of derivative security
|
Direct |
20,925
+44.7%
|
$125,550
$6.93 P/Share
|
|
Jun 18
2025
|
Hollings Renton |
SELL
Open market or private sale
|
Direct |
3,015
-37.78%
|
$69,345
$23.97 P/Share
|
|
Jun 18
2025
|
Dennis M Fenton |
SELL
Open market or private sale
|
Direct |
3,015
-37.78%
|
$69,345
$23.97 P/Share
|